Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China
Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China
复制标题
DOI：
10.1136/annrheumdis-2020-217627
复制
发表时间：
2020-08-01
影响因子：
27.4
通讯作者：
Dong, Lingli
中科院分区：
文献类型：
--
作者：
Ye, Cong;Cai, Shaozhe;Dong, Lingli
目的 2019冠状病毒病（COVID-19）风湿病患者的临床特征尚未见报道。本研究旨在描述风湿病患者中COVID-19的临床特征，并为临床实践中处理这种情况提供信息。方法这是一项回顾性病例系列研究。收集了2020年1月13日至3月15日同济医院确诊的2326例COVID-19患者的去识别化数据，包括性别、年龄、实验室和放射学结果、症状、体征和用药史，其中21例合并风湿性疾病。结果风湿性组和非风湿性组的住院时间和死亡率相似，而风湿性病例中呼吸衰竭更常见 （38% 与 10%，p
Objective The clinical features of rheumatic patients with coronavirus disease 2019 (COVID-19) have not been reported. This study aimed to describe the clinical features of COVID-19 in rheumatic patients and provide information for handling this situation in clinical practice.Methods This is a retrospective case series study. Deidentified data, including gender, age, laboratory and radiological results, symptoms, signs, and medication history, were collected from 2326 patients diagnosed with COVID-19, including 21 cases in combination with rheumatic disease, in Tongji Hospital between 13 January and 15 March 2020.Results Length of hospital stay and mortality rate were similar between rheumatic and non-rheumatic groups, while the presence of respiratory failure was more common in rheumatic cases (38% vs 10%, p